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Enterovirus 71 (EV-71) is involved in epidemics of hand, 
foot, and mouth disease (HFMD) and has been reported 
to occur with severe neurological complications in east-
ern and south-east Asia. In other geographical areas, 
the transmission of this virus is poorly understood. We 
used large sequence datasets (of the gene encoding 
the viral protein 1, VP1) and a Bayesian phylogenetic 
approach to compare the molecular epidemiology and 
geographical spread patterns of EV-71 subgenogroups 
B4, B5, C1, C2, and C4 in Europe relative to other parts 
of the world. For the study, European countries con-
sidered were European Union (EU) Member States and 
Iceland, Norway and Switzerland. Viruses of the B4, 
B5, and C4 subgenogroups circulate mainly in eastern 
and south-east Asia. In Europe sporadic introductions 
of these subgenogroups are observed, however C1 and 
C2 viruses predominate. The phylogenies showed evi-
dence of multiple events of spread involving C1 and C2 
viruses within Europe since the mid-1990s. Two waves 
of sporadic C2 infections also occurred in 2010 and 
2013. The 2007 Dutch outbreak caused by C2 and the 
occurrence of B5 and C4 infections in the EU between 
2004 and 2013 arose while the circulation of C1 viruses 
was low. A transmission chain involving a C4 virus was 
traced from Japan to the EU and then further to Canada 
between 2001 and 2006. Recent events whereby 
spread of viruses have occurred from, to, and within 
Europe appear to be involved in the long term survival 
of EV-71, highlighting the need for enhanced surveil-
lance of this virus.
Introduction
The results of infections by enterovirus 71 (EV-71) range 
from the absence of symptoms to acute manifesta-
tions, including hand, foot, and mouth disease (HFMD) 
as well as neurological conditions such as acute men-
ingitis, encephalitis, and poliomyelitis-like disease [1]. 
The outbreaks caused by this virus since the late 1990s 
pose serious threats to public health in countries of 
eastern and south-east Asia (http://www.wpro.who.
int/emerging_diseases/HFMD/en/) because a number 
of infections are involved in cardiopulmonary failure 
and neurological diseases which, in infancy (<1 year-
old), can lead to death [2]. During the HFMD epidem-
ics in China between 2010 and 2012, there were 1,737 
laboratory-confirmed deaths, of which 93% were asso-
ciated with EV-71 infections [3]. The occurrence of fatal-
ities in Asia, notably in Cambodia, China, Malaysia, and 
Vietnam does not necessarily indicate that the EV-71 
variants and strains circulating in these countries have 
a greater virulence [4]. Rather, this probably reflects 
the high total number of infections (HFMD cases and 
asymptomatic infections). The overall disease burden 
caused by EV-71 led health authorities to develop sur-
veillance systems in parts of eastern and south-east 
Asia. The World Health Organization provides a guide 
to clinical management and outbreak prevention of 
EV-71 infection (http://www.wpro.who.int/emerging_
diseases/documents/HFMDGuidance/en/), for which 
five inactivated EV-71 vaccine candidates are being 
evaluated in clinical trials [5].
Unlike for some areas in eastern and south-east 
Asia, there is currently no particular epidemiological 
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surveillance of EV-71 infections in the European Union 
(EU). The virus was involved in outbreaks of neurologi-
cal diseases in the 1970s in Sweden (1973), Bulgaria 
(1975; 44 fatalities), Hungary (1978; 47 fatalities), and 
France (1979) [6-9]. Sero-epidemiological surveys con-
ducted on samples from 1999 to 2007 in Germany 
showed that ca 12% of children aged < 5 years, and ca 
40 to 60% of adults develop neutralising antibodies 
against EV-71, which suggests that mild and mostly 
undiagnosed EV-71 infections occur in the general pop-
ulation [10,11]. We and others showed that acute EV-71 
infections are regularly investigated in patients admit-
ted to hospital in a number of European countries, 
such as Austria, France, Germany and the Netherlands 
[12-14]. Severe manifestations have been occasionally 
reported in France [15,16], and most documented EV-71 
infections in EU Member States included sporadic 
cases of febrile illness and acute meningitis [17,18].
EV-71 is one serotype among a hundred human entero-
viruses (EVs) that belongs to the Picornaviridae family. 
Virus strains can be divided into six genogroups des-
ignated A to F [19] but since the mid-1960s only geno-
groups B and C have been reported in outbreaks and 
individual cases of infection. The virus strains of the 
two major genogroups are classified into subgeno-
groups B0 to B5 and C1 to C5 on the basis of genetic 
relationships [20]. Subgenogroups B4, B5, and C4 
Figure 1 
Comparison of phylogenies of five enterovirus 71 subgenogroups (B4, B5, C1, C2, C4) with indications of geographical 
origins of sample sequences, 1986–2013 (n=675 sequences) 
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The chronogram trees were inferred with the 1D gene encoding the capsid viral protein 1 sequence datasets for subgenogroups B4/B5 (panel 
A), C1 (panel B), C2 (panel C), and C4 (panel D). 
The tree topologies show the genetic relationships between taxa sampled over the periods indicated on the x-axis (calendar years). The 
phylogenetic relationships were inferred with a Bayesian method using a relaxed molecular-clock model. 
For clarity, the sequence names are not included in the tree. Asterisks indicate key nodes with posterior probability (pp) density values > 0.90. 
Each branch tip represents a sampled virus sequence. 
The branches in the genealogies of each subgenogroup were coloured to investigate relationships between phylogenetic clustering and the 
geographical origins of taxa. The geographical areas where the virus strains were sampled are indicated by different colours: blue, Europe 
(including European Union Member States, Iceland, Norway and Switzerland); light blue, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan 
Russia and Ukraine; green, North America; and red, Australia and eastern and south-east Asia.
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are mainly restricted to Asian countries while subge-
nogroups C1 and C2 are chiefly found in Europe [20]. 
Many aspects of the epidemiological and evolutionary 
dynamics of circulating virus strains remain unknown. 
In particular, how virus transmission occurs over time, 
across space, and among genogroups has not been 
extensively studied in geographical areas other than 
eastern and south-east Asia [21]. We investigated the 
evolutionary dynamics of EV-71 to determine the origin 
of virus strains sampled in Europe and their relation-
ships with viruses reported elsewhere in the world. 
To this aim, we used large sequence datasets of virus 
isolates sampled worldwide since the mid-1980s, 
which were mainly representative of EV-71 subgeno-
groups circulating in Europe and eastern and south-
east Asia. We estimated the genetic diversity with the 
1D gene encoding the capsid viral protein 1 (hereafter 
designated 1DVP1) over time, across geographical areas, 
and among subgenogroups, something that, to our 
knowledge, has never been done on such a large scale 
before.
Figure 2 
Plots of genetic diversitya over time (calendar years) reconstructed for the enterovirus 71 subgenogroups C1 (panel A), C2 
(panel B), and C1/C2 (panel C), 1985–2013 
AUS: Australia; AUT: Austria; DEU: Germany; ESP: Spain; FRA: France; GBR: United Kingdom; HUN: Hungary; JPN: Japan; MYS: Malaysia; NLD: 
the Netherlands; NOR: Norway; SGP: Singapore; THA: Thailand; TWN: Taiwan; USA: United states.
a Global genetic diversity over time was estimated with gene 1D encoding the capsid viral protein 1 (1DVP1) for each subgenogroup. Genetic 
diversity is estimated with the Bayesian skyline plot model and is expressed as log10Net (Ne: effective size of virus population; t: 
generation time). Genetic diversity reflects the effective number of infections averaged over time under the assumption of a neutral 
evolutionary process.
On panels A and B the geographical areas where the virus strains were detected frequently are indicated above the peaks of genetic diversity. 
On panel C, plots estimated for the EV-71 subgenogroups C1 and C2 are superimposed on the same time scale. The epidemic peaks are 
numbered. The sporadic introductions of EV-71/C4 strains in European Union Member States (as described in this study and [34]) and 
Canada are indicated with open triangles. The introduction events in Russia are shown with full triangles. The introduction events of the 
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Virus samples, gene amplification, and 
nucleotide sequencing
The enterovirus samples studied consisted of 64 
EV-71 strains isolated in Austria (n=1), France (n=43), 
Germany (n=12), and Hungary (n=8) between 2003 
and 2013, and 33 strains recovered between 2001 and 
2013 in Azerbaijan (n=1), Kazakhstan (n=1), Kyrgyzstan 
(n=1), Ukraine (n=1) and Russia (n=29). The EV-71 iso-
lates were collected as part of routine clinical work-up.
The 1DVP1 sequences were determined in the virus iso-
lates with the previously described genotyping meth-
ods [12,22]. The complete 1D gene sequence was 
amplified with either standard single-round (amplicon 
length of 1,200 bp) or semi-nested (amplicon of 2,240 
bp) polymerase chain reaction (PCR) assays. The nucle-
otide (nt) sequences determined in this study were 
deposited in publicly available sequence databases 
under the accession numbers HG934162 to HG934296.
Data collection and compilation of nucleotide 
sequence datasets
The sequences determined were analysed with 
sequences obtained from GenBank. The 1DVP1 sequence 
datasets were constructed by collating all GenBank 
entries (as of July 2013 for the 1DVP1 locus) including a 
sequence of the VP1 capsid protein for any human iso-
late of EV-71. Entries reporting nt sequences of < 891 nt 
were discarded and only sequences with fully speci-
fied dates (year) and countries of origin were used. 
The sequence datasets were constructed with BioEdit 
v.7.2.5 software (http://www.mbio.ncsu.edu/bioedit/
bioedit.html) and were compiled with all sequences 
determined in our laboratory. The EV-71 1DVP1 gene 
sequences were distributed into five datasets corre-
sponding to subgenogroups B4/B5 (n = 217 sequences), 
C1 (n = 280), C2 (n = 322), and C4 (n = 675). On the basis 
of earlier phylogenetic data indicating that subgeno-
groups B4 and B5 had a common ancestor [21], we ana-
lysed jointly their sequences to increase the sample 
size. To investigate the EV-71/C4 subgenogroup, an ini-
tial dataset of 775 complete sequences was downsized 
to 675 by removing all sequences but one in genetic 
clusters containing multiple sequences with ≥ 99.5% nt 
identity with one another.
Coalescent estimation of divergence dates and 
evolutionary rates
Genealogical trees of EV-71 subgenogroups were 
reconstructed with the Bayesian evolutionary analy-
sis by sampling trees (BEAST) v1.7.5 programme [23]. 
Uncorrelated lognormal prior distributions of substitu-
tion rates among lineages were used for the molecular 
clock model [24]. The evolutionary history was recon-
structed with the substitution general time reversible 
(GTR) model. The phylogenetic parameters were co-
estimated in the different analyses by a Markov chain 
Monte Carlo (MCMC) process involving 100 x 106 to 200 
x 106 generations to ensure convergence of parameter 
estimates. The Tracer v.1.5 programme (http://evolve.
zoo.ox.ac.uk/Evolve/Software.html) was used to check 
for convergence and mixing (operator effective sample 
size > 200). The trees estimated with the MCMC proce-
dure were sampled to obtain a final 20,000 trees. Mean 
estimates and 95% highest probability density (HPD) 
intervals calculated for each operator were compiled 
by analysing the output files obtained from the BEAST 
programme with the Tracer v.1.5 programme. Maximum 
clade credibility (MCC) trees were calculated with the 
TreeAnnotator v.1.7.5 programme (http://evolve.zoo.
ox.ac.uk/Evolve/Software.html) and topological sup-
port was assessed by estimating the values of the pos-
terior probability (pp) density of each node.
Reconstruction of the demographic history 
and geographical spread of enterovirus 
subgenogroups
The Bayesian skyline plot model (BSP) does not assume 
a pre-defined model of demography [25]. It infers a 
demographic parameter representing ‘virus popula-
tion size’, also referred to as relative genetic diversity, 
using the coalescent theory and temporal information 
of the molecular data (virus collection date). Genetic 
diversity is the product of the effective size of the virus 
population (Ne) and the generation time (t), and reflects 
the effective number of infections averaged over time 
under the assumption of a neutral evolutionary pro-
cess. In our study, this model was used to investigate 
possible variations in virus population size over time 
for subgenogroups B4, B5, C1, C2, and C4 to describe 
past epidemiological events on a continuous time scale 
using large sequence datasets for the 1DVP1 gene. EV-71 
infections are characterised by epidemic transmission 
in a number of countries, a high rate of asymptomatic 
or pauci-symptomatic infections, and short-lived acute 
infections in susceptible individuals. Accordingly, the 
skyline plot model appears epidemiologically better 
suited than the other demographic models (constant 
population size, exponential growth, logistic growth, 
and expansion growth) for modelling the spread of 
EV-71 populations and thus for reconstructing the dif-
fusion of HFMD over time and across geographical 
regions. The BSP analyses were done with a lognor-
mal distribution (piecewise-constant population size 
model) to account for variation in substitution rates 
among the phylogenies. The countries where the virus 
strains were collected were used as discrete character 
states (or traits) in the phylogeographical analysis to 
estimate changes of geographical locations on the phy-
logenetic trees [26]. The geographical locations of the 
ancestral nodes were co-estimated with the phylogeny 
by using a discrete phylogeographical diffusion model 
(symmetrical substitution model). Bayesian stochastic 
search variable selection was also used for identifying 
the statistically significant transition rates between 
locations. TreeAnnotator software was used to produce 
the MCC tree, with the branches coloured by traits.
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Figure 3 
Spatial and temporal distribution of enterovirus 71 lineages showing the geographical dissemination of subgenogroups C1 
(panel A) and C2 (panel B)
AUS: Australia; AUT: Austria; AZE: Azerbaijan; CHE: Switzerland; DEU: Germany; ESP: Spain; FIN: Finland; FRA: France; GBR: United Kingdom; 
GEO: Georgia; HUN: Hungary; ISL: Iceland; JPN: Japan; KGZ: Kyrgyzstan; LVA: Latvia; MYS: Malaysia; NLD: Netherlands; NOR: Norway; PHL: 
Philippines; RUS: Russia; SGP: Singapore; THA: Thailand; TWN: Taiwan; UKR: Ukraine; USA: United States.
The MCC tree was obtained from a Bayesian MCMC analysis (discrete phylogeographical model) and shows for more clarity the most relevant 
parts of tree topologies (time is indicated as calendar years). The FigTree programme was used to display a number of information. 
Branches and circles at the tree nodes are coloured according to the geographical location that had the highest probability. The size of each 
circle represents the location probability. Line width indicates the posterior probability of the corresponding lineage (thick lines indicate 
high posterior probability values). The tree topologies were used to determine the phylogenetic patterns (numbered sequentially) showing 
the most probable virus spread events. The main features of the most probable virus spread events (i.e. geographical location, location 
































































































































































































































































































Phylogenies of five enterovirus 71 
subgenogroups estimated with datasets of the 
1D gene encoding the capsid viral protein 1 
We used the large number of 1DVP1 sequences deter-
mined in circulating strains to obtain a comprehen-
sive comparison of virus transmission among EV-71 
subgenogroups. The country of virus isolation was 
checked for each sequence to determine the distribu-
tion in four main geographical areas: (i) eastern and 
south-east Asia as well as Australia, (ii) Azerbaijan, 
Georgia, Kazakhstan, Kyrgyzstan, Russia and Ukraine 
(iii) Europe (whereby data originated from EU Member 
States, as well as Iceland, Norway and Switzerland) 
and (iv) North America, as observed in the genealo-
gies. The phylogenies displayed a ‘ladder-like’ shape 
mainly characterised by a long trunk with short side 
branches, evidence of rapid extinction of lineages over 
time (Figure 1). These topologies arose from a com-
bined effect of temporal sampling in various countries 
and rapid coalescence. A number of long side branches 
were also inferred in the C1, C2, and C4 trees, which 
indicated transmission of lineages over time and the 
persistence of these lineages alongside more recent 
ones. Of the subgenogroups examined, all but one (i.e. 
subgenogroup C1) were inferred to arise in the 1990s 
(Figures 1A, 1C, 1D). The time to most recent common 
ancestor (TMRCA) of subgenogroup EV-71/C1 was esti-
mated in 1983.5 (95% HPD: 1982.2−1984.4) (Figure 1B). 
Most B4, B5 and C4 lineages were restricted to east-
ern and south-east Asia while subgenogroups C1 and 
C2 originated from this geographical area as well as 
European countries and Russia over the sampling peri-
ods. After 2000, several phylogenetically independent 
EV-71 C2 lineages were inferred to have circulated in 
Europe, during three main periods in 2007, 2010, and 
2013. The C4 phylogeny also included a few lineages 
in EU Member States and Russia, which suggests that 
a number of persons in these countries sporadically 
acquired the virus from individuals elsewhere in the 
world, most probably eastern and south-east Asia.
Figure 4 
Geographical spread of enterovirus 71 subgenogroups C1 (green) and C2 (blue) among different countries, 1998–2011
AUS: Australia; AUT: Austria; DEU: Germany; ESP: Spain; FIN: Finland; FRA: France; GBR: United Kingdom; GEO: Georgia; HRV: Croatia; HUN: 
Hungary; JPN: Japan; MYS: Malaysia; NLD: Netherlands; RUS: Russia; SGP: Singapore; THA: Thailand.
The most probable virus spread events of EV-71 strains analysed in Figure 3 are schematically represented in the Figure above. Line width 





















Genealogy-based population dynamics of 
enterovirus 71 subgenogroups
The demographic histories showed variations between 
the five subgenogroups. The pattern estimated by our 
coalescent-based reconstruction for subgenogroup 
C4 clearly indicated an annual series of increases in 
genetic diversity interspersed with genetic bottle-
necks. This pattern was caused by the large HFMD epi-
demics recently observed in China [3] and confirmed 
the usefulness of the BSP model for investigating EV-71 
transmission. 
We provide the detailed data obtained for the most fre-
quent subgenogroups (C1 and C2) in Europe (Figure 2). 
The pattern estimated for subgenogroup C1 (Figure 2A) 
depicted successive variations in virus population size. 
This demographic pattern was consistent with a few 
outbreaks over time and across different geographical 
areas as documented by epidemiological data [20,27]. 
This pattern may also indicate uninterrupted global cir-
culation of the virus. 
The pattern reconstructed for EV-71/C2 disclosed two 
distinct rises in virus population size (Figure 2B). The 
subgenogroup experienced a first sharp increase in 
1998 that coincided with the occurrence of a large 
HFMD epidemic in Taiwan [28]. The virus population 
size then slowly decreased over several years. The sec-
ond exponential rise in virus population size (in 2007) 
was of a high magnitude. This major increase in virus 
genetic diversity coincided with the occurrence of an 
outbreak in the Netherlands [29] and a concomitant 
rise in virus circulation in Austria, France, and Germany 
[12]. The transmission of the virus remained at a sus-
tained high level after the 2007 epidemic, yet the dif-
ferent lineages sampled in 2010 and 2013 (Figure 1C) 
Figure 5 
Bayesian analyses of the spatial and temporal spread of an enterovirus 71 subgenogroup C4 lineage, 2002–2006 
AUT: Austria; CAN: Canada; CHN: China; DEU: Germany; FRA: France; HRV: Croatia; HUN: Hungary; JPN: Japan.
The topology was drawn with the sequence sample corresponding to the subtree indicated in Figure 1. The geographical locations and the 
location probabilities estimated with a discrete phylogeographical model are indicated for the most relevant nodes. The most probable 































































were not associated with increases in virus population 
size. 
A combination of the C1 and C2 patterns showed that 
the decrease in the EV-71/C1 population size in 1996 
was concurrent with the initial occurrence of EV-71/
C2 (Figure 2C). The 1998 increase in virus population 
size (Taiwan epidemic, subgenogroup C2, peak 1) coin-
cided with a lower genetic diversity of EV-71/C1. The 
marked increase in C2 genetic diversity in 2007 (peak 
5) also occurred in Europe during a period of low C1 
diversity. The C1 pattern showed three yearly ascend-
ing rises (peaks 2, 3, and 4) during a long period of low 
genetic diversity of the C2 virus. The population size of 
both C1 and C2 subgenogroups remained low over the 
years 2004 to 2006 and 2008 to 2013, periods during 
which the EV-71/C4 subgenogroup occurred in several 
European countries (Austria, Croatia, France, Germany, 
and Hungary) and Canada (see below). EV-71/B5 
caused an outbreak in Denmark (2007) [30] and a spo-
radic infection in France (2013) [31].
Spread of enterovirus 71/C1 between distinct 
countries
Spread of EV-71 between different countries was inves-
tigated with the MCC trees of the above analyses. A 
phylogenetic pattern indicative of a probable virus 
spread event between two nodes was defined as fol-
lows: (i) the nodes exhibited pp > 0.9, (ii) the inferred 
location probabilities were > 0.7 at both nodes, and (iii) 
the difference between the TMRCA values or the 95% 
HPD interval values of nodes were in a range of one 
year. With this conservative approach, the MCC tree 
topology inferred for subgenogroup C1 indicated a 
total of 13 consistent virus transmission events (Figure 
3A). Eight phylogenetic patterns (numbered 03–05, 
07–09, 11 and 12 in Figure 3A) indicated that the 
virus was transmitted between persons within various 
European countries. The United Kingdom, with a prob-
ability of 0.98, was likely the country of origin in three 
inferred virus spread events (numbered 03, 08, and 12, 
Figure 3A) to France (probabilities of 0.95) and one to 
Spain (0.99). France was inferred as the origin of two 
spread events, respectively to Germany and the United 
Kingdom. The EV-71/C1 tree also showed that virus 
spread occurred from Austria (location probability, 
0.83) to Germany and from the Netherlands (0.84) to 
Finland. Three other phylogenetic patterns (numbered 
06, 10, and 13 in Figure 3A) were indicative of long dis-
tance virus spread from a EU Member State to either 
Australia or Japan (n = 2 events). In the spread event 
number 13 (Figure 3A), the probability of the United 
Kingdom being the source country was estimated to 
be 0.56 against 0.28 for France. Two consistent phylo-
genetic patterns showed virus spread from Malaysia 
(location probability ≥ 0.94) respectively to Singapore 
and to Thailand.
A schematic representation of all virus spread events 
described above is shown in Figure 4.
Spread of enterovirus 71/C2 between distinct 
countries
In the MCC tree inferred for subgenogroup C2 (Figure 
3B), 12 phylogenetic patterns indicated that the virus 
spread between distinct European countries, Georgia, 
and Russia. The most frequent likely countries of origin 
of infected persons in the inferred virus spread events 
were the Netherlands (n = 5 events; location probability 
range: 0.87–1) and France (n = 5; 0.74–0.98) followed 
by Finland and Germany. The 2007 epidemic line-
age in the Netherlands was involved in only one virus 
spread event (Figure 3; number 7). Three virus spread 
events were estimated between distant countries: from 
Finland to Georgia and from France to Russia. An addi-
tional event of spread of the virus from Japan (location 
probability: 0.85) to Spain was also inferred in the 
genealogy before 1995 (not shown in Figure 3B). All the 
virus spread events occurring after 1998 are shown in 
Figure 4.
Spread of enterovirus 71/C4 between distinct 
countries
We analysed separately a sequence subset corre-
sponding to the lineage highlighted in Figure 1D. The 
distributions of geographical location probabilities 
were indicated for the most relevant nodes in the MCC 
tree inferred for this sequence subset and were used 
to investigate virus spread between countries (Figure 
5). The phylogeny pattern indicated that between 2001 
and 2002 a C4 virus strain spread from China to Japan, 
and from there to the EU in early 2003. The virus was 
disseminated in different EU Member States between 
2003 and 2004. It was sampled in Croatia in 2005 and 
the phylogenetic analysis estimated a probability of 
0.92 that the source country was Germany. The same 
virus strain also moved from the EU to Canada (sam-
pling year 2006). The phylogenetic analysis suggested 
that the virus was spread from Germany with a prob-
ability of 0.72.
Discussion
The recent reporting of sporadic circulation of EV-71 
strains of the ‘Asian subgenogroups’ B5 [30,31] and 
C4 [32-34] in European countries makes it important to 
determine the evolutionary origins and spatiotemporal 
spread of EV-71 infections in geographical areas other 
than eastern and south-east Asia. There is a large body 
of literature on the molecular epidemiology of EV-71 
[35] but, to our knowledge, the spread of this virus has 
not yet been analysed explicitly with recently devel-
oped phylogeographical models [26]. In this report, we 
therefore applied demographic and phylogeographi-
cal analyses to compare the population structure and 
the dissemination patterns of EV-71 subgenogroups 
in Europe and Asia. We found that the EV-71 subgeno-
groups exhibit distinct phylodynamic patterns and that 
these patterns differed from those of past epidemics in 
frequency and geographical location. The transmission 
history of subgenogroup C2 was characterised by fewer 
increases in genetic diversity than in subgenogroups 
C1 and C4. For instance, the genetic diversity pattern 
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of subgenogroup C2 shows clearly the two outbreaks 
(Taiwan, 1998 and the Netherlands, 2007) documented 
in the literature [28,29]. The variations in genetic diver-
sity over the study period also reflect gaps in virus sam-
pling over time and surveillance differences between 
countries. In Europe, EV-71 sequences are determined 
solely in patients admitted to hospitals and in a few 
countries only, whereas in a number of Asian countries 
real-time epidemiological data are obtained from senti-
nel surveillance of HFMD cases. In this study, we used 
only full-length EV-71 1DVP1 sequences because phylo-
genetic trees based on short-length sequences did not 
provide a high level of statistical confidence. Partial nt 
sequences were notably determined for virus genotyp-
ing and ranged over different parts of the 1DVP1 gene. 
Accordingly, we had to discard a certain amount of 
sequence data, some from Europe, which might have 
been helpful in phylogenetic analysis of virus spread.
We show how transmission of EV-71 strains (subgeno-
groups C1, C2, and C4) occurs in Europe as discrete 
and temporally defined virus introductions, occasion-
ally followed by limited local spread. The only excep-
tion to this pattern was the epidemic expansion in the 
Netherlands in 2007. Interestingly, we found limited 
phylogenetic evidence that the Dutch outbreak was the 
source of a large spread to other European countries. 
The phylogenetic patterns also show that European 
countries may experience multiple virus introduction 
events within the same year. This dissemination mode 
was observed within particular countries (e.g. France, 
Germany) for both subgenogroups C1 and C2 but was 
more clearly seen during three waves of infections in 
2007, 2010, and 2013 (subgenogroup C2). The epide-
miological and biological factors involved are unknown 
but the occurrence of these infection waves is consist-
ent with the hypothesis that the sustained circulation 
of an EV-71 strain throughout Europe depends on the 
proportion of susceptible hosts in different countries. 
The data may alternatively indicate that the immunity 
elicited by the C1 and C2 infections is cross-protective, 
as suggested by earlier studies that identified com-
mon epitopes and suggested that human immune sera 
among virus strains of different EV-71 subgenogroups 
have cross-neutralization properties [36]. In this 
respect, we also provide phylogenetic evidence that 
the spread of the C2 virus across European countries in 
2007 happened at a time when C1 infections had been 
transmitted at low rates for at least three years.
It is particularly noteworthy that the transmission of 
EV-71 strains C1 and C2 in Europe is mainly depend-
ent on the frequency of virus spread events between 
neighbouring countries. This has been previously 
described for EV-71 [37] and for another EV, coxsacki-
evirus B5 [38]. The present study also indicates that 
the long-term survival of EV-71 (C1 and C2) depends 
on continued virus transmission between individuals 
across larger geographical areas, notably Russia and 
Asia. We also reconstructed a consistent transmission 
chain caused by a C4 virus strain throughout Europe 
(Austria, Croatia, France, Germany, and Hungary), 
which suggests that the virus persisted between 2003 
and 2005. The chain was brought about by a virus from 
Japan which eventually reached Canada between 2005 
and 2006. Transmission of the C1 and C2 infections 
was low during the whole period in Europe. Similarly, 
the recent C4 infections in France (2012), and Russia 
(2013) arose during a transmission trough of both C1 
and C2 infections. Thus, transcontinental transmis-
sion events between individuals should be considered 
in the global epidemiology of the virus: they provide 
the epidemiological bases for explaining the long-term 
survival of lineages despite abrupt extinctions that 
drastically reduce virus diversity after the occurrence 
of outbreaks in particular locations.
Earlier hypotheses proposed that yearly epidemics 
of EV-71 in Japan arose from spread of the virus from 
neighbouring countries [37]. We suggest that virus 
strains are sustained by complex migration dynamics 
involving Europe and Russia, and possibly other geo-
graphical regions. This argument is lent weight by a 
recent study reporting the occurrence of EV-71 C4 in 
Denmark in 2012 and 2013 [39]. Our Bayesian analy-
sis of the partial 1DVP1 sequences showed that the C4 
viruses isolated in Denmark were distributed in two 
distinct phylogenetic clusters, which suggests inde-
pendent virus sources (data not shown). Thus, the 
frequency of epidemics in Asian countries, the involve-
ment of EV-71 in neurological conditions, the recent iso-
lation of C4 variant strains in Europe, and the spread 
patterns of the virus between distant and neighbouring 
countries underline a need for enhanced surveillance 
of EV-71 infections in Europe using common enterovi-
rus genotyping methods.
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